首页> 外文期刊>MedChemComm >Novel valdecoxib derivatives by ruthenium(II)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes - synthesis and COX-2 inhibition activity
【24h】

Novel valdecoxib derivatives by ruthenium(II)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes - synthesis and COX-2 inhibition activity

机译:通过钌(II)的新型Valdecoxib衍生物 - 用醇酸氧化物的腈氧化物的丙氧化物 - 合成和COX-2抑制活性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Novel valdecoxib-based cyclooxygenase-2 inhibitors were synthesized in one step via 1,3-dipolar cycloaddition of nitrile oxides with a series of eleven aryl alkynes, six of them described for the first time. Application of Ru(II)-catalysis leads preferably to the formation of the 3,4-diaryl-substituted isoxazoles, while under thermal heating with base the 3,5-diaryl substitution pattern is favoured. The new the 3,4-diaryl-substituted isoxazoles possessing a small substituent (H and Me) displayed high COX-2 inhibition affinity (IC_(50) = 0.042- 0.073 μM) and excellent selectivity (COX-2 SI > 2000). In contrast, the 3,5-diaryl substituted compounds displayed almost no COX activity. The introduction of a 4-fluorophenyl substituent resulted in retained high COX-2 affinity, making these compounds together with the feasible one step reaction promising candidates for the development of fluorine-18 labelled radiotracers.
机译:基于新的基于Valdecoxib的环加氧基酶-2抑制剂在一步一步通过1,3-偶极环加成的腈氧化物,其中六个芳基炔烃系列是第一次描述的六个。 Ru(II)的施用 - 催化剂优选地形成3,4-二芳基取代的异恶唑,而在与基部的热加热下的3,5-二芳基取代图案中是有利的。 具有具有小取代基(H和ME)的3,4-二芳基取代的异恶唑显示出高COX-2抑制亲和力(IC_(50)=0.042-0.073μm)和优异的选择性(COX-2 Si> 2000)。 相反,3,5-二芳基取代的化合物显示几乎没有COX活性。 引入4-氟苯基取代基使得保留高COX-2亲和力,使这些化合物与可行的一种阶梯反应的候选候选者一起制备,用于开发氟-18标记的放射性机构的候选者。

著录项

  • 来源
    《MedChemComm》 |2018年第3期|共11页
  • 作者单位

    Department of Radiopharmaceutical and Chemical Biology Helmholtz-Zentrum Dresden-Rossendorf Institute of Radiopharmaceutical Cancer Research Bautzner Landstra?e 400 01328 Dresden Germany.;

    Department of Radiopharmaceutical and Chemical Biology Helmholtz-Zentrum Dresden-Rossendorf Institute of Radiopharmaceutical Cancer Research Bautzner Landstra?e 400 01328 Dresden Germany.;

    Department of Inorganic Solid State Chemistry Institute of Chemistry University of Rostock Albert Einstein Stra?e 3a 18059 Rostock Germany;

    Department of Inorganic Solid State Chemistry Institute of Chemistry University of Rostock Albert Einstein Stra?e 3a 18059 Rostock Germany;

    Department of Radiopharmaceutical and Chemical Biology Helmholtz-Zentrum Dresden-Rossendorf Institute of Radiopharmaceutical Cancer Research Bautzner Landstra?e 400 01328 Dresden Germany.;

    Department of Radiopharmaceutical and Chemical Biology Helmholtz-Zentrum Dresden-Rossendorf Institute of Radiopharmaceutical Cancer Research Bautzner Landstra?e 400 01328 Dresden Germany.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

    Novel valdecoxib; derivatives by ruthenium(II)-promoted 1; 3-dipolar; alkynes - synthesis and COX-2 inhibition activity;

    机译:新的Valdecoxib;通过钌(ii)的衍生物 - 丙氧化物1;3-偶极;炔烃合成和COX-2抑制活性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号